title: Hemostatic abnormalities in dogs with hemangiosarcoma.
abstract: The hemostasis profiles of 24 dogs with histologically confirmed hemangiosarcoma were prospectively evaluated. Microangiopathic hemolysis was defined as the presence of schistocytes; disseminated intravascular coagulation was defined as 1) thrombocytopenia, 2) fibrin(ogen) degradation products greater than 10 micrograms/mL, 3) prolongation of one or more coagulation times (activated partial thromboplastin time or one-stage prothrombin time) by greater than 25% of the control, 4) fragmented red blood cells (greater than or equal to 1+ based on a semiquantitative grading scale), and 5) fibrinogen less than or equal to 80 mg/dL. Three of the five criteria listed above had to be met for disseminated intravascular coagulation to be diagnosed. Fifty percent of the dogs were considered to have disseminated intravascular coagulation at presentation. Thrombocytopenia was present in 75% of the dogs and was the most common abnormality. The mean platelet count was 137,800/microL. Twenty-five percent of the dogs died as a result of the hemostatic abnormalities. Only 12% of the dogs had microangiopathic hemolysis without other evidence of disseminated intravascular coagulation. Hemostatic abnormalities are present in many dogs with hemangiosarcoma at the initial clinical presentation and represent an important clinical finding.
authors.affiliation: Department of Veterinary Clinical Sciences, Ohio State University, College of Veterinary Medicine, Columbus.
authors.forename: A S
authors.initials: AS
authors.lastname: Hammer
authors.forename: C G
authors.initials: CG
authors.lastname: Couto
authors.forename: C
authors.initials: C
authors.lastname: Swardson
authors.forename: D
authors.initials: D
authors.lastname: Getzy
mesh_terms: D000818:Animals; D004211:Disseminated Intravascular Coagulation / Q000209:etiology / Q000662:veterinary*; D004283:Dog Diseases / Q000097:blood*; D004285:Dogs; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D006394:Hemangiosarcoma / Q000097:blood / Q000150:complications / Q000662:veterinary*; D006461:Hemolysis; D006487:Hemostasis; D010314:Partial Thromboplastin Time / Q000662:veterinary; D010976:Platelet Count / Q000662:veterinary; D011446:Prospective Studies; D011517:Prothrombin Time / Q000662:veterinary; D013921:Thrombocytopenia / Q000209:etiology / Q000662:veterinary*
chemical_list: D005338:Fibrin Fibrinogen Degradation Products